Whitehouse Station-based global healthcare provider Merck announced Thursday the appointment of Robert M. Davis, 47, as its new executive vice president and chief financial officer, effective April 23, 2014.
According to the announcement, Davis will oversee corporate strategy and business development. He will succeed Peter N. Kellogg, 58.
"Rob is an accomplished executive with significant financial and operational expertise, including as a CFO, and will be an exceptional addition to our team," said Kenneth C. Frazier, chairman and chief executive officer, Merck. "Rob's broad, global business and healthcare experience, which encompasses commercial, R&D, quality, regulatory, manufacturing and supply chain, will be an asset to us in implementing a significantly streamlined, more flexible cost structure and operating model, while enabling us to focus on our highest potential growth opportunities."
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy